Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-14 Tax Withholding |
2025-02-18 4:54 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
4,559 | $3.18 | 295,717 (Direct) |
View |
2025-02-14 Option Award |
2025-02-18 4:54 pm |
N/A 2035-02-13 |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
217,700 | $0 | 295,717 (Direct) |
View |
2025-02-13 Tax Withholding |
2025-02-18 4:54 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
1,863 | $3.2 | 295,717 (Direct) |
View |
2024-11-07 Tax Withholding |
2024-11-12 4:17 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
1,102 | $6.04 | 94,939 (Direct) |
View |
2024-11-07 Exercise |
2024-11-12 4:17 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
3,750 | $0 | 94,939 (Direct) |
View |
2024-09-18 Tax Withholding |
2024-09-20 4:13 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
1,837 | $6.38 | 81,791 (Direct) |
View |
2024-09-16 Tax Withholding |
2024-09-17 5:12 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
661 | $6.36 | 97,878 (Direct) |
View |
2024-09-16 Exercise |
2024-09-17 5:12 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
2,250 | $0 | 97,878 (Direct) |
View |
2024-03-07 Option Award |
2024-03-08 7:21 pm |
N/A 2032-02-13 |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
45,000 | $0 | 45,000 (Direct) |
View |
2024-02-14 Option Award |
2024-02-15 5:02 pm |
N/A 2034-02-13 |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
202,000 | $0 | 247,339 (Direct) |
View |
2024-02-13 Tax Withholding |
2024-02-15 5:02 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
1,301 | $6.53 | 247,339 (Direct) |
View |
2023-09-18 Option Award |
2023-09-19 7:21 pm |
N/A 2033-09-17 |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
136,000 | $0 | 157,640 (Direct) |
View |
Ownership |
2023-09-19 7:20 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
0 | $0 | 215,515 (Direct) |
View |